Foghorn Therapeutics Inc. Common Stock (FHTX) is a publicly traded Healthcare sector company. As of August 6, 2026, FHTX trades at $4.98 with a market cap of $285.35M and a P/E ratio of -4.09. FHTX moved +1.95% today. Year to date, FHTX is -9.63%; over the trailing twelve months it is -2.40%. Its 52-week range spans $2.94 to $6.95. Analyst consensus is strong buy with an average price target of $11.75. Rallies surfaces FHTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover FHTX: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $11.75.
| Metric | Value |
|---|---|
| Price | $4.98 |
| Market Cap | $285.35M |
| P/E Ratio | -4.09 |
| EPS | $-1.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.95 |
| 52-Week Low | $2.94 |
| Volume | 160 |
| Avg Volume | 0 |
| Revenue (TTM) | $28.22M |
| Net Income | $-75.32M |
| Gross Margin | 0.00% |
5 analysts cover FHTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.75.